Kytopen and Excellos Collaborate to Transform Non-Viral Cell Therapy Manufacturing Kytopen and Excellos join forces to enhance non-viral cell therapy manufacturing, aiming for scalable and consistent production in advanced therapies.

Kytopen and Excellos Collaborate to Transform Non-Viral Cell Therapy Manufacturing #USA #Cambridge,_Massachusetts #Kytopen #Flowfect_Tx #Excellos

Kytopen Expands Board with Industry Experts for Advanced Cell Therapy Growth Kytopen Corp. has appointed industry veterans Henry Hebel and Joe Gentile to its board, enhancing its commitment to innovative cell therapy manufacturing processes.

Kytopen Expands Board with Industry Experts for Advanced Cell Therapy Growth #United_States #Cambridge #Cell_Therapy #Kytopen #Flowfect_Tx